---
title: NOVEL THERAPEUTIC APPROACHES IN THALASSEMIAS, SICKLE CELL DISEASE AND OTHER
  RED CELL DISORDERS
date: '2024-05-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38820588/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240601181226&v=2.18.0.post9+e462414
source: Blood
description: In this last decade, a deeper understanding of the pathophysiology of
  hereditary red cell disorders and the development of novel classes of pharmacologic
  agents have provided novel therapeutic approaches to thalassemias, sickle cell disease
  (SCD) and other red cell disorders. Here, we analyze and discuss the novel therapeutic
  options according to their targets and taking into consideration the complex process
  of erythroid differentiation, maturation, and survival of erythrocytes in ...
disable_comments: true
---
In this last decade, a deeper understanding of the pathophysiology of hereditary red cell disorders and the development of novel classes of pharmacologic agents have provided novel therapeutic approaches to thalassemias, sickle cell disease (SCD) and other red cell disorders. Here, we analyze and discuss the novel therapeutic options according to their targets and taking into consideration the complex process of erythroid differentiation, maturation, and survival of erythrocytes in ...